Hepatic steatosis is a driving force for NAFLD because increased intracellular TG accumulation induces inflammation, oxidative stress and insulin resistance by generating lipotoxic intermediates, which leads to NASH, fibrosis and cirrhosis [2]. The gene discussed is INS; the disease is Hepatic steatosis.